Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial. Preusser M, Garde-Noguera J, Garcia-Mosquera JJ, Gion M, et al. Nat Med 2025;31:2797-2805.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Preusser M, Garde-Noguera J, Garcia-Mosquera JJ, Gion M, et al. Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial. Nat Med 2025;31:2797-2805.
PMID: 40447851